The nebulizer devices market was estimated at USD 1.13 billion in 2023 and is likely to grow at a CAGR of 6.0% during 2024-2030 to reach USD 1.71 billion in 2030.
Nebulizers are respiratory drug delivery therapeutic devices that help to transform liquid drugs into aerosols or mists and deliver them directly to the lungs. The nebulization technique is commonly used to treat respiratory diseases such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). These devices are electrically powered and rechargeable. Nebulizers are specifically used to deliver liquid medication to the breathing passage, thus reducing the bulging of the mucous membrane caused by pollutants.